ApoptoSENS

Biotechnology company developing CAR-NK cell therapies to target and eliminate senescent cells implicated in aging and age-related diseases.

Location
United States
Founded
2022
Investors
1
Categories
biotech, longevity, cell-therapy, senescence, car-nk

Investors

NameLocationTypeStagesPortfolio
VitaDAODecentralized (Global)dao
seed
7